RTSL (Rapid Therapeutic Science Laboratories) Cyclically Adjusted FCF per Share: $-0.73 (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rapid Therapeutic Science Laboratories Cyclically Adjusted FCF per Share?

Rapid Therapeutic Science Laboratories RTSL Cyclically Adjusted FCF per Share is $-0.73 as of Jun. 2023.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Rapid Therapeutic Science Laboratories's adjusted free cash flow per share for the three months ended in Jun. 2023 was $-0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.73 for the trailing ten years ended in Jun. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-24), Rapid Therapeutic Science Laboratories's current stock price is $0.0001. Rapid Therapeutic Science Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 was $-0.73. Rapid Therapeutic Science Laboratories's Cyclically Adjusted Price-to-FCF of today is .


Rapid Therapeutic Science Laboratories  (OTCPK:RTSL) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Rapid Therapeutic Science Laboratories Cyclically Adjusted FCF per Share Related Terms


Rapid Therapeutic Science Laboratories Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Rapid Therapeutic Science Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Therapeutic Science Laboratories Cyclically Adjusted FCF per Share Chart

Rapid Therapeutic Science Laboratories Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Rapid Therapeutic Science Laboratories Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.74 -0.73

RTSL vs VRAYQ, NNMX, ABT: Cyclically Adjusted FCF per Share Comparison

For the Shell Companies subindustry, Rapid Therapeutic Science Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Therapeutic Science Laboratories Cyclically Adjusted Price-to-FCF vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Rapid Therapeutic Science Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Rapid Therapeutic Science Laboratories's Cyclically Adjusted Price-to-FCF falls into.



Rapid Therapeutic Science Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rapid Therapeutic Science Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.001/305.1090*305.1090
=-0.001

Current CPI (Jun. 2023) = 305.1090.

Rapid Therapeutic Science Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 0.000 234.149 0.000
201312 0.000 233.049 0.000
201403 -0.019 236.293 -0.025
201406 0.000 238.343 0.000
201409 0.000 238.031 0.000
201412 0.000 234.812 0.000
201503 -0.019 236.119 -0.025
201506 -0.019 238.638 -0.024
201509 -0.028 237.945 -0.036
201512 -0.028 236.525 -0.036
201603 -0.019 238.132 -0.024
201606 -0.065 241.018 -0.082
201609 -0.019 241.428 -0.024
201612 -0.046 241.432 -0.058
201703 -0.074 243.801 -0.093
201706 -0.056 244.955 -0.070
201709 -0.046 246.819 -0.057
201712 -0.055 246.524 -0.068
201803 -1.662 249.554 -2.032
201806 -1.729 251.989 -2.093
201809 -0.021 252.439 -0.025
201812 -0.250 251.233 -0.304
201903 -0.229 254.202 -0.275
201906 -0.146 256.143 -0.174
201909 -0.146 256.759 -0.173
201912 -0.010 256.974 -0.012
202003 -0.025 258.115 -0.030
202006 -0.033 257.797 -0.039
202009 -0.115 260.280 -0.135
202012 -0.110 260.474 -0.129
202103 -0.075 264.877 -0.086
202106 -0.057 271.696 -0.064
202109 -0.102 274.310 -0.113
202112 -0.094 278.802 -0.103
202203 -0.095 287.504 -0.101
202206 -0.033 296.311 -0.034
202209 -0.021 296.808 -0.022
202212 -0.005 296.797 -0.005
202303 -0.005 301.836 -0.005
202306 -0.001 305.109 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.73 mean?
Rapid Therapeutic Science Laboratories (RTSL) has a Cyclically Adjusted FCF per Share of $-0.73 as of Jun. 2023. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Rapid Therapeutic Science Laboratories and its competitors.
Is Rapid Therapeutic Science Laboratories' Cyclically Adjusted FCF per Share too high?
Rapid Therapeutic Science Laboratories' current Cyclically Adjusted FCF per Share is $-0.73.
How does Rapid Therapeutic Science Laboratories' Cyclically Adjusted FCF per Share compare to VRAYQ and NNMX?
Rapid Therapeutic Science Laboratories' Cyclically Adjusted FCF per Share of $-0.73 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Diversified Financial Services company?
A good Cyclically Adjusted FCF per Share depends on the Diversified Financial Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Rapid Therapeutic Science Laboratories and its competitors. Rapid Therapeutic Science Laboratories's current Cyclically Adjusted FCF per Share is $-0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Therapeutic Science Laboratories stock overvalued right now?
Rapid Therapeutic Science Laboratories (RTSL) has a current Cyclically Adjusted FCF per Share of $-0.73. The current Cyclically Adjusted FCF per Share is $-0.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Rapid Therapeutic Science Laboratories (RTSL), the current Cyclically Adjusted FCF per Share is $-0.73 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rapid Therapeutic Science Laboratories Business Description

Address 558 County Road 472, De Leon, TX, USA, 76444
Rapid Therapeutic Science Laboratories Inc currently has no operations and operates as a blank check company.